MedRx Co., Ltd (4586.T)

JPY 84.0

(-3.45%)

Gross Profit Summary of MedRx Co., Ltd

  • MedRx Co., Ltd's latest annual gross profit in 2023 was 26 Million JPY , down -54.28% from previous year.
  • MedRx Co., Ltd's latest quarterly gross profit in 2024 Q2 was 220.43 Million JPY , up 2095.96% from previous quarter.
  • MedRx Co., Ltd reported a annual gross profit of 56.86 Million JPY in annual gross profit 2022, up 834.17% from previous year.
  • MedRx Co., Ltd reported a annual gross profit of 6.08 Million JPY in annual gross profit 2021, down -94.53% from previous year.
  • MedRx Co., Ltd reported a quarterly gross profit of -11.04 Million JPY for 2024 Q1, up 2.63% from previous quarter.
  • MedRx Co., Ltd reported a quarterly gross profit of -11.34 Million JPY for 2023 Q4, down -203.17% from previous quarter.

Annual Gross Profit Chart of MedRx Co., Ltd (2023 - 2019)

Historical Annual Gross Profit of MedRx Co., Ltd (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 26 Million JPY -54.28%
2022 56.86 Million JPY 834.17%
2021 6.08 Million JPY -94.53%
2020 111.17 Million JPY -32.46%
2019 164.6 Million JPY 0.0%

Peer Gross Profit Comparison of MedRx Co., Ltd

Name Gross Profit Gross Profit Difference
Pharma Foods International Co., Ltd. 48.75 Billion JPY 99.947%
Takeda Pharmaceutical Company Limited 2184.96 Billion JPY 99.999%
Sumitomo Pharma Co., Ltd. 187.98 Billion JPY 99.986%
Shionogi & Co., Ltd. 369.08 Billion JPY 99.993%
Wakamoto Pharmaceutical Co.,Ltd. 3.54 Billion JPY 99.266%
Nippon Shinyaku Co., Ltd. 97.01 Billion JPY 99.973%
Kaken Pharmaceutical Co., Ltd. 38.22 Billion JPY 99.932%
Eisai Co., Ltd. 586.41 Billion JPY 99.996%
Morishita Jintan Co., Ltd. 5.99 Billion JPY 99.567%
Hisamitsu Pharmaceutical Co., Inc. 78.97 Billion JPY 99.967%
Mochida Pharmaceutical Co., Ltd. 52.07 Billion JPY 99.95%
Fuso Pharmaceutical Industries,Ltd. 13.51 Billion JPY 99.808%
Nippon Chemiphar Co., Ltd. 7.73 Billion JPY 99.664%
Tsumura & Co. 68.81 Billion JPY 99.962%
Kissei Pharmaceutical Co., Ltd. 37.34 Billion JPY 99.93%
Torii Pharmaceutical Co., Ltd. 24.79 Billion JPY 99.895%
Towa Pharmaceutical Co., Ltd. 81.38 Billion JPY 99.968%
Fuji Pharma Co., Ltd. 16.51 Billion JPY 99.843%
Zeria Pharmaceutical Co., Ltd. 50.18 Billion JPY 99.948%
KYORIN Holdings, Inc. 51.4 Billion JPY 99.949%
Taiko Pharmaceutical Co.,Ltd. 1.07 Billion JPY 97.59%
Daito Pharmaceutical Co.,Ltd. 9.83 Billion JPY 99.736%
SymBio Pharmaceuticals Limited 4.41 Billion JPY 99.411%
Mizuho Medy Co.,Ltd. 8.02 Billion JPY 99.676%
Solasia Pharma K.K. 337 Million JPY 92.285%
Modalis Therapeutics Corporation -731 Thousand JPY 3656.772%
ASKA Pharmaceutical Holdings Co.,Ltd. 30.66 Billion JPY 99.915%
Sawai Group Holdings Co., Ltd. 54.31 Billion JPY 99.952%
Cyfuse Biomedical K.K. 37.74 Million JPY 31.115%
Toho Holdings Co., Ltd. 112.98 Billion JPY 99.977%
Koa Shoji Holdings Co.,Ltd. 6.63 Billion JPY 99.608%